Absence of full drug-susceptibility data for TB patients can result in amplifying resistance, compromise treatment outcomes: HaystackAnalytics report aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Swiss pharmaceutical firm Roche has sounded alarm against clinical trials conducted by Zydus Lifesciences on its biologic drug Perjeta, a widely-used breast cancer treatment. The Swiss company has filed a complaint against the Indian drug maker over alleged critical gaps in the clinical trial of a drug originally developed by Roche
The five-day event, which commenced on Wednesday (August 23), kick-started with interactive workshops and training sessions for emergency medicine experts.
The key aims of the trial are: generate evidence for HIV and TB programmes to integrate alcohol reduction counselling; bring about behavioural changes to ensure lower alcohol intake.